CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![mobile-app-clinical-trials-GettyImages-1321691686]( "Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually Control")
Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually ControlThis piece breaks down why Agentic AI monitoring, nearly a third of trial cost, resets the economics, and why the first CRO to move first resets the price floor for everyone else.
-
![Data analysis science and big data with AI technology-GettyImages-1979289147]( "Trust In AI Agents Has To Be Earned Continuously, Not Just Once")
Trust In AI Agents Has To Be Earned Continuously, Not Just OnceThis white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.
-
![Meeting, team, medical case review, treatment plan, research-GettyImages-2265129844]( "Why Operational Expertise Defines Great Clinical Trial Services")
Why Operational Expertise Defines Great Clinical Trial ServicesGreat trial technology isn't enough on its own. See why the operational expertise behind it can make or break your study's success.
-
![clinical-sites-GettyImages-2057440780]( "Why Are Clinical Trial Sites Are Absorbing Increased Complexity?")
Why Are Clinical Trial Sites Are Absorbing Increased Complexity?Site coordinators are overwhelmed by disconnected systems. Learn how unified trial technology can ease that load and free up time for patients.
-
![AI medical cloud technology, analyzing patient health data, artificial intelligence agents, smart medical records, digital healthcare solutions-GettyImages-2229247291]( "Tech-Enabled FSP Delivery")
Tech-Enabled FSP DeliveryStruggling with data silos and delayed trial visibility? See how combining AI with smarter data integration helps teams gain real-time visibility without adding headcount.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
It’s about time.
Modern ePRO/eCOA.
Solved.
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
Enabling organizations of all sizes to transform their business through better use of technology.
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
Patients shouldn’t have to jump through hoops. Discover an innovative portal that lets them handle travel and reimbursement directly—securely, simply, and without extra calls to the site.
See our exciting new solution for medical monitors, Revvity Signals Software Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
CENTRAL LABORATORIES SOLUTIONS
- Rave TSDV - Improve CRA Efficiency And Reduce Site Burden
- NDA/MAA Preparation Survival Guide: Overcoming Data Analysis Hurdles
- Feasibility As A Service From Consulting & Analytics
- Comprehensive Advanced Therapy Analytics
- Data Lifecycle At CRC
- Power Patient-Focused Data Collection Across Hybrid Clinical Trials
- ICH E6(R3) Is Here: How Should You Handle It?
- Synthetic Control Arm®: The Smart External Control Arm Solution
- RWD Solutions
- What Our Portal Does For Sites, Sponsors, And Patients
VIDEOS
NEWS
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer